The Bellcast
Bridge the investing and markets knowledge gap with the Bell Direct Bellcast. From bite-size thought snippets, to full length interviews with the top executives of leading ASX200 companies, you'll be informed and ready for any market movement.
Show episodes
In this episode of the From the helm, Bell Financial Group’s Grady Wulff speaks with Flynn Gold (ASX: FG1) Managing Director, Neil Marston about the company’s high-grade gold discovery at the Golden Ridge project in Tasmania. In this video Neil covers: • (1:38): what Flynn Gold has uncovered at Golden Ridge • (2:08): h
In this special edition of Bell Direct’s From the helm series, we take a closer look at LinQ Minerals – a company set to make waves with its upcoming IPO. With investor interest in gold and copper ramping up, Bell Direct Market Analyst Grady Wulff speaks with Executive Chairman Clive Donner to discuss LinQ’s standout a
Join our Market Analyst, Grady Wulff as she sits down with Bell Potter"s Analyst, John Hester as he discusses an update on the below healthcare stocks. In this video, John discusses: - (3:15) Telix"s Pharmaceuticals (ASX:TLX) - (7:34) Clarity Pharmaceuticals (ASX:CU6) - (10:54) Avita Medical (ASX:AVH) - (12:16) Mesobla
In this Bell Direct macro update, we break down the latest March quarter CPI figures and what they could mean for the RBA’s next move. With trimmed mean inflation easing to within target and key categories like services and housing shifting, could a rate cut be on the horizon? Watch now for expert analysis and market
From the helm: EMVision Medical Devices (ASX:EMV) CEO & Managing Director, Scott Kirkland
Join Market Analyst Grady Wulff as she sits down with Scott Kirkland, CEO and Managing Director of EMVision Medical Devices (ASX:EMV), to discuss how the company’s pioneering portable brain scanner is set to revolutionize stroke diagnosis and care. In this video, Scott covers: • (0:31) EMVision’s history and breakthrou
In this latest instalment of Bell Direct’s From the helm series, we kick off 2025 with an exciting deep dive into the healthcare sector. Host Bell Direct’s Market Analyst, Grady Wulff sits down with Opthea (ASX:OPT) CEO, Fred Guerard to discuss the company’s remarkable 168% share price surge over the past six months as